CUR - 1.12 Pre-market now at 1.45/1.53 Neuralstem Presents Positive Updated Data from Phase 2 Study of NSI-189 in Major Depressive Disorder at the 56th American College of Neuropsychopharmacology (ACNP) Annual Meeting http://stockcharts.com/c-sc/sc?s=CUR&p=D&b=5&g=0&i=t94424286155&r=1512476422478 http://stockcharts.com/c-sc/sc?s=CUR&p=W&b=5&g=0&i=t15845046023&r=1512476442763